Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapyYuze Wu, Kongming Wu|Molecular Cancer|2022Cited by 458
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumorsMing Yi, Kongming Wu, Dechao Jiao et al.|Journal of Hematology & Oncology|2022Cited by 178